TNM Staging in Oral Squamous Cell Carcinoma: Evolution, Validation, and Priorities for Refinement

Tumor-node-metastasis (TNM) staging standardizes the description of disease extent in oral squamous cell carcinoma. The eighth edition of the American Joint Committee on Cancer (AJCC) staging system incorporated depth of invasion into T classification and extranodal extension into N classification. This narrative review examines the evidence underlying these revisions, their validation, and priorities for further refinement. Multicenter cohorts, registry analyses, and systematic reviews generally support improved prognostic stratification, although gains in discrimination vary and are often modest. Measurement variability and heterogeneous outcomes within categories remain important limitations. We propose an evaluation roadmap that links each candidate to a defined classification weakness, reproducible measurement, independent incremental value, and feasibility. For patients treated with upfront surgery, positive-node count combined with extranodal extension status warrants first priority for evaluation, followed by standardized bone-invasion descriptors. Quantitative extranodal extension requires further standardization. Additional pathological features and prediction models may complement individualized risk assessment. Current evidence neither establishes a ceiling for anatomical staging nor demonstrates that further anatomical subdivision alone will resolve residual risk variation. Retaining TNM as the core staging system and supplementing it with validated models is a practical approach. Hybrid stage groupings require separate evaluation. Clinical, pathological, and post-treatment settings should remain distinct. These priorities reflect evidence synthesis and author interpretation, not guideline-level recommendations. Greater prognostic accuracy alone does not establish treatment benefit.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-17
DOI
https://doi.org/10.3390/cancers18223674
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TNM Staging in Oral Squamous Cell Carcinoma: Evolution, Validation, and Priorities for Refinement

Chao-Qun Niu, Yue He, Wen-Tao Shi, Kai-Chen Shan et al.
Cancers
Head and Neck Cancer Studies
article

TNM Staging in Oral Squamous Cell Carcinoma: Evolution, Validation, and Priorities for Refinement

Chao-Qun Niu, Yue He, Wen-Tao Shi, Kai-Chen Shan, Zhi-Yuan Zhang, Rong Zhou
article en

Abstract

Tumor-node-metastasis (TNM) staging standardizes the description of disease extent in oral squamous cell carcinoma. The eighth edition of the American Joint Committee on Cancer (AJCC) staging system incorporated depth of invasion into T classification and extranodal extension into N classification. This narrative review examines the evidence underlying these revisions, their validation, and priorities for further refinement. Multicenter cohorts, registry analyses, and systematic reviews generally support improved prognostic stratification, although gains in discrimination vary and are often modest. Measurement variability and heterogeneous outcomes within categories remain important limitations. We propose an evaluation roadmap that links each candidate to a defined classification weakness, reproducible measurement, independent incremental value, and feasibility. For patients treated with upfront surgery, positive-node count combined with extranodal extension status warrants first priority for evaluation, followed by standardized bone-invasion descriptors. Quantitative extranodal extension requires further standardization. Additional pathological features and prediction models may complement individualized risk assessment. Current evidence neither establishes a ceiling for anatomical staging nor demonstrates that further anatomical subdivision alone will resolve residual risk variation. Retaining TNM as the core staging system and supplementing it with validated models is a practical approach. Hybrid stage groupings require separate evaluation. Clinical, pathological, and post-treatment settings should remain distinct. These priorities reflect evidence synthesis and author interpretation, not guideline-level recommendations. Greater prognostic accuracy alone does not establish treatment benefit.

CancersVol. 18(22)
Shanghai Jiao Tong University (CN), Shanghai Institute of Nutrition and Health (CN), Shanghai Ninth People's Hospital (CN), University of Chinese Academy of Sciences (CN)
Shanghai Municipal Health Commission, National Natural Science Foundation of China
Good health and well-being
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon